How do you determine what is considered sufficient clinical evidence for an IVD to satisfy NB?

There is no set number, and it depends on the risk of the IVD. You must tell your story and address the data you generate pre-market and the data you generate post-market. This includes items such as complaints, vigilance, and post-market performance follow-up activities.

Related Videos

Video FAQ

What are some best practices for defining your intended purpose statement under IVDR?

Video FAQ

As a regulatory director, what IVDR transition milestones would you set for the end of 2020?

Video FAQ

How do you determine what is considered sufficient clinical evidence for an IVD to satisfy NB?
Explore All Resources

We are passionate about your success. Tell us more about your needs so we can help.

Book a Consultation

GLOBAL BOTTOM CTA INSTRUCTIONS:

To display custom copy instead of global copy in this section, please go to Show Global Content for Bottom CTA? toggle in the "Contents" tab to the left, toggle it off, save, and then REFRESH the page editor, the custom text will then show up and ready to be edited.

Turning the global content back on will be the same process, go to the toggle and toggle it back on, save and refresh!